These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 25924832)

  • 21. Efficacy and safety of recombinant human C1-inhibitor for the treatment of attacks of hereditary angioedema: European open-label extension study.
    Moldovan D; Reshef A; Fabiani J; Kivity S; Toubi E; Shlesinger M; Triggiani M; Montinaro V; Cillari E; Realdi G; Cancian M; Visscher S; Zanichelli A; Relan A; Cicardi M
    Clin Exp Allergy; 2012 Jun; 42(6):929-35. PubMed ID: 22909164
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks.
    Craig TJ; Levy RJ; Wasserman RL; Bewtra AK; Hurewitz D; Obtułowicz K; Reshef A; Ritchie B; Moldovan D; Shirov T; Grivcheva-Panovska V; Kiessling PC; Keinecke HO; Bernstein JA
    J Allergy Clin Immunol; 2009 Oct; 124(4):801-8. PubMed ID: 19767078
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nanofiltered human C1 inhibitor concentrate (Cinryze®): in hereditary angioedema.
    Lyseng-Williamson KA
    BioDrugs; 2011 Oct; 25(5):317-27. PubMed ID: 21942916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preprocedural administration of nanofiltered C1 esterase inhibitor to prevent hereditary angioedema attacks.
    Grant JA; White MV; Li HH; Fitts D; Kalfus IN; Uknis ME; Lumry WR
    Allergy Asthma Proc; 2012; 33(4):348-53. PubMed ID: 22856635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human C1-esterase inhibitor concentrate (Berinert).
    Keating GM
    BioDrugs; 2009; 23(6):399-406. PubMed ID: 19894781
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An evidence based therapeutic approach to hereditary and acquired angioedema.
    Bork K
    Curr Opin Allergy Clin Immunol; 2014 Aug; 14(4):354-62. PubMed ID: 24983294
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health-Related Quality of Life with Subcutaneous C1-Inhibitor for Prevention of Attacks of Hereditary Angioedema.
    Lumry WR; Craig T; Zuraw B; Longhurst H; Baker J; Li HH; Bernstein JA; Anderson J; Riedl MA; Manning ME; Keith PK; Levy DS; Caballero T; Banerji A; Gower RG; Farkas H; Lawo JP; Pragst I; Machnig T; Watson DJ
    J Allergy Clin Immunol Pract; 2018; 6(5):1733-1741.e3. PubMed ID: 29391286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanofiltered C1 esterase inhibitor for treatment of laryngeal attacks in patients with hereditary angioedema.
    Riedl MA; Lumry WR; Li HH; Craig TJ; Fitts D; Kalfus I; Uknis ME
    Am J Rhinol Allergy; 2013; 27(6):517-21. PubMed ID: 24274230
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic analysis of human plasma-derived pasteurized C1-inhibitor concentrate in adults and children with hereditary angioedema: a prospective study.
    Martinez-Saguer I; Rusicke E; Aygören-Pürsün E; von Hentig N; Klingebiel T; Kreuz W
    Transfusion; 2010 Feb; 50(2):354-60. PubMed ID: 19788511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of C1 esterase inhibitor concentrate in treatment of cutaneous attacks of hereditary angioedema.
    Bork K; Craig TJ; Bernstein JA; Feuersenger H; Machnig T; Staubach P
    Allergy Asthma Proc; 2015; 36(3):218-24. PubMed ID: 25803207
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hereditary angioedema: long-term treatment with one or more injections of C1 inhibitor concentrate per week.
    Bork K; Hardt J
    Int Arch Allergy Immunol; 2011; 154(1):81-8. PubMed ID: 20664282
    [TBL] [Abstract][Full Text] [Related]  

  • 32. C1-inhibitor therapy for hereditary angioedema attacks: prospective patient assessments of health-related quality of life.
    Bewtra AK; Levy RJ; Jacobson KW; Wasserman RL; Machnig T; Craig TJ
    Allergy Asthma Proc; 2012; 33(5):427-31. PubMed ID: 23026185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of a C1 Inhibitor Concentrate in Adults ≥65 Years of Age with Hereditary Angioedema: Findings from the International Berinert
    Bygum A; Martinez-Saguer I; Bas M; Rosch J; Edelman J; Rojavin M; Williams-Herman D;
    Drugs Aging; 2016 Nov; 33(11):819-827. PubMed ID: 27699634
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [EFFICACY, PHARMACOKINETICS, PHARMACODYNAMICS, AND SAFETY OF INTRAVENOUS C1 INHIBITOR FOR LONG-TERM PROPHYLAXIS AND TREATMENT OF BREAKTHROUGH ATTACKS IN JAPANESE SUBJECTS WITH HEREDITARY ANGIOEDEMA: A PHASE 3 OPEN-LABEL STUDY].
    Fukunaga A; Morita E; Miyagi T; Eto K; Shimizu A; Kagami S; Yamamoto H; Vardi M; Tang Y; Wang Y; Hide M
    Arerugi; 2020; 69(3):192-203. PubMed ID: 32435020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subcutaneous administration of human C1 inhibitor with recombinant human hyaluronidase in patients with hereditary angioedema.
    Riedl MA; Lumry WR; Li HH; Banerji A; Bernstein JA; Ba M; Bjrkander J; Magerl M; Maurer M; Rockich K; Chen H; Schranz J
    Allergy Asthma Proc; 2016 Nov; 37(6):489-500. PubMed ID: 27931305
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Nanofiltered C1-esterase inhibitor for the acute management and prevention of hereditary angioedema attacks due to C1-inhibitor deficiency in children.
    Lumry W; Manning ME; Hurewitz DS; Davis-Lorton M; Fitts D; Kalfus IN; Uknis ME
    J Pediatr; 2013 May; 162(5):1017-22.e1-2. PubMed ID: 23312695
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term prophylaxis of hereditary angioedema with a pasteurized C1 inhibitor concentrate.
    Tallroth GA
    Int Arch Allergy Immunol; 2011; 154(4):356-9. PubMed ID: 20975289
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of weight on the efficacy and safety of C1 esterase inhibitor concentrate for the treatment of acute hereditary angioedema.
    Bernstein JA; Machnig T; Keinecke HO; Whelan GJ; Craig TJ
    Clin Ther; 2014 Apr; 36(4):518-25. PubMed ID: 24661784
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION study.
    Martinez-Saguer I; Cicardi M; Suffritti C; Rusicke E; Aygören-Pürsün E; Stoll H; Rossmanith T; Feussner A; Kalina U; Kreuz W
    Transfusion; 2014 Jun; 54(6):1552-61. PubMed ID: 24266596
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Usage of C1-Inhibitor in Hereditary Angioedema: Berinert Registry Data.
    Riedl MA; Bygum A; Lumry W; Magerl M; Bernstein JA; Busse P; Craig T; Frank MM; Edelman J; Williams-Herman D; Feuersenger H; Rojavin M;
    J Allergy Clin Immunol Pract; 2016; 4(5):963-71. PubMed ID: 27286778
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.